[{"address1": "331 Oyster Point Boulevard", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "650 481 6770", "website": "https://pliantrx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Pliant Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases. The company's lead candidate includes bexotegrast, an oral, small-molecule, dual selective inhibitor of av\u00df6 and av\u00df1 integrins, which has completed phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of av\u00df1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins av\u00df8 and av\u00df1 for the treatment of solid tumors; and PLN-101325, a phase 1-ready program for treatment of the muscular dystrophies, including duchenne muscular dystrophy. Pliant Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.", "fullTimeEmployees": 171, "companyOfficers": [{"maxAge": 1, "name": "Dr. Bernard  Coulie M.B.A., M.D., Ph.D.", "age": 58, "title": "President, CEO & Director", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 1078624, "exercisedValue": 0, "unexercisedValue": 4323229}, {"maxAge": 1, "name": "Dr. Keith Lamont Cummings M.B.A., M.D.", "age": 47, "title": "Chief Financial Officer", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 713074, "exercisedValue": 234570, "unexercisedValue": 1088282}, {"maxAge": 1, "name": "Dr. Rik  Derynck Ph.D.", "title": "Scientific Founder & Member of Scientific Advisory Board", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dean  Sheppard M.D.", "title": "Scientific Founder & Member of Scientific Advisory Board", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Hal  Chapman M.D.", "title": "Scientific Founder & Member of Scientific Advisory Board", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Delphine  Imbert Ph.D.", "title": "Chief Technical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher S. Keenan", "title": "Vice President of Investor Relations & Corporate Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Monica  Sandberg Ph.D.", "title": "Vice President, Regulatory & Compliance", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lily  Cheung", "age": 50, "title": "Chief Human Resources Officer", "yearBorn": 1974, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tim  Machajewski Ph.D.", "title": "Senior VP & Head of Research", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.23, "open": 1.23, "dayLow": 1.19, "dayHigh": 1.235, "regularMarketPreviousClose": 1.23, "regularMarketOpen": 1.23, "regularMarketDayLow": 1.19, "regularMarketDayHigh": 1.235, "payoutRatio": 0.0, "beta": 1.303, "forwardPE": -0.6515711, "volume": 494375, "regularMarketVolume": 494375, "averageVolume": 1166641, "averageVolume10days": 843640, "averageDailyVolume10Day": 843640, "bid": 0.9288, "ask": 1.57, "bidSize": 2, "askSize": 2, "marketCap": 74353760, "fiftyTwoWeekLow": 1.1, "fiftyTwoWeekHigh": 13.71, "allTimeHigh": 43.92, "allTimeLow": 1.1, "fiftyDayAverage": 1.5186, "twoHundredDayAverage": 1.48895, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -107586248, "profitMargins": 0.0, "floatShares": 50936624, "sharesOutstanding": 61449385, "sharesShort": 3182879, "sharesShortPriorMonth": 3851283, "sharesShortPreviousMonthDate": 1763078400, "dateShortInterest": 1765756800, "sharesPercentSharesOut": 0.051799998, "heldPercentInsiders": 0.025929999, "heldPercentInstitutions": 0.84624, "shortRatio": 1.66, "shortPercentOfFloat": 0.0531, "impliedSharesOutstanding": 61449385, "bookValue": 3.26, "priceToBook": 0.37116566, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -175499008, "trailingEps": -2.86, "forwardEps": -1.85705, "enterpriseToEbitda": 0.572, "52WeekChange": -0.90539485, "SandP52WeekChange": 0.17318606, "quoteType": "EQUITY", "currentPrice": 1.21, "targetHighPrice": 4.0, "targetLowPrice": 2.0, "targetMeanPrice": 3.25, "targetMedianPrice": 3.5, "recommendationKey": "none", "numberOfAnalystOpinions": 4, "totalCash": 241796992, "totalCashPerShare": 3.935, "ebitda": -188127008, "totalDebt": 59857000, "quickRatio": 13.771, "currentRatio": 13.935, "debtToEquity": 29.883, "returnOnAssets": -0.32868, "returnOnEquity": -0.64269996, "freeCashflow": -110867128, "operatingCashflow": -158210000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "PLRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "epsTrailingTwelveMonths": -2.86, "epsForward": -1.85705, "epsCurrentYear": -2.44679, "priceEpsCurrentYear": -0.4945255, "fiftyDayAverageChange": -0.30859995, "fiftyDayAverageChangePercent": -0.20321345, "twoHundredDayAverageChange": -0.27894998, "twoHundredDayAverageChangePercent": -0.18734677, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-06-03", "cryptoTradeable": false, "marketState": "CLOSED", "shortName": "Pliant Therapeutics, Inc.", "longName": "Pliant Therapeutics, Inc.", "regularMarketChangePercent": -1.62601, "regularMarketPrice": 1.21, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1591191000000, "postMarketChangePercent": -0.82644546, "postMarketPrice": 1.2, "postMarketChange": -0.00999999, "regularMarketChange": -0.02, "regularMarketDayRange": "1.19 - 1.235", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1166641, "fiftyTwoWeekLowChange": 0.110000014, "fiftyTwoWeekLowChangePercent": 0.10000001, "fiftyTwoWeekRange": "1.1 - 13.71", "fiftyTwoWeekHighChange": -12.5, "fiftyTwoWeekHighChangePercent": -0.9117432, "fiftyTwoWeekChangePercent": -90.53948, "earningsTimestamp": 1762462800, "earningsTimestampStart": 1762462800, "earningsTimestampEnd": 1762462800, "isEarningsDateEstimate": false, "corporateActions": [], "postMarketTime": 1766787113, "regularMarketTime": 1766782800, "exchange": "NMS", "messageBoardId": "finmb_325980525", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "displayName": "Pliant Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-12-27"}]